Insider Trading & Ownership - Smith Jason Drew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Smith Jason Drew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-09
Sale
2024-09-12
1:51 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
1,521$13.08$19,89531,893
(Direct)
View
2024-02-01
Sale(A)
2024-02-05
9:16 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
4,993$15.78$78,79023,414
(Direct)
View
2024-01-31
Sale
2024-02-02
7:12 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
4,993$15.74$78,59055,748
(Direct)
View
2023-08-31
Sale
2023-09-05
4:28 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
3,800$18.01$68,43818,407
(Direct)
View
2023-01-31
Sale
2023-02-02
1:04 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
1,636$10.12$16,55679,707
(Direct)
View
2022-08-31
Sale
2022-09-02
11:40 am
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
3,606$7.21$25,99920,510
(Direct)
View
2022-01-31
Sale
2022-02-02
4:35 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
414$7.58$3,13846,616
(Direct)
View
2021-11-30
Sale
2021-12-02
1:16 pm
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
3,803$12.03$45,75023,697
(Direct)
View
2021-05-17
Purchase
2021-05-18
11:35 am
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
2,500$15.71$39,2752,500
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-09
Exercise
2024-09-12
1:51 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
3,333$031,893
(Direct)
View
2024-01-31
Exercise
2024-02-02
7:12 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
10,000$055,748
(Direct)
View
2024-01-31
Option Award
2024-02-02
7:12 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
16,500$055,748
(Direct)
View
2023-09-07
Option Award
2023-09-08
3:41 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
10,000$010,000
(Direct)
View
2023-08-31
Exercise
2023-09-05
4:28 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
8,334$018,407
(Direct)
View
2023-01-31
Exercise
2023-02-02
1:04 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
3,333$079,707
(Direct)
View
2023-01-31
Option Award
2023-02-02
1:04 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
60,000$079,707
(Direct)
View
2022-08-31
Exercise
2022-09-02
11:40 am
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
8,333$020,510
(Direct)
View
2022-01-31
Exercise
2022-02-02
4:35 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
833$046,616
(Direct)
View
2022-01-31
Option Award
2022-02-02
4:35 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
37,500$046,616
(Direct)
View
2021-11-30
Exercise
2021-12-02
1:16 pm
N/A
N/A
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
8,333$023,697
(Direct)
View
2021-06-05
Option Award
2021-06-08
2:33 pm
N/A
2031-05-31
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
15,000$015,000
(Direct)
View
2021-01-31
Option Award
2021-02-02
3:55 pm
N/A
2031-01-30
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
10,500$010,500
(Direct)
View
2020-10-01
Option Award(A)
2020-10-05
4:35 pm
N/A
2030-09-30
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
85,000$085,000
(Direct)
View
2020-09-09
Option Award
2020-09-10
12:14 pm
N/A
2030-09-08
UroGen Pharma Ltd.URGNSmith Jason Drew
General Counsel
85,000$085,000
(Direct)
View
(A) Indicate amendment filing.